cpg odn Search Results


tlr9 agonist agatolimod  (MedChemExpress)
93
MedChemExpress tlr9 agonist agatolimod
Tlr9 Agonist Agatolimod, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr9 agonist agatolimod/product/MedChemExpress
Average 93 stars, based on 1 article reviews
tlr9 agonist agatolimod - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cpg a dna  (Hycult Biotech)
92
Hycult Biotech cpg a dna
Cpg A Dna, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg a dna/product/Hycult Biotech
Average 92 stars, based on 1 article reviews
cpg a dna - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
human cpg oligodeoxynucleotides  (Hycult Biotech)
93
Hycult Biotech human cpg oligodeoxynucleotides
Human Cpg Oligodeoxynucleotides, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cpg oligodeoxynucleotides/product/Hycult Biotech
Average 93 stars, based on 1 article reviews
human cpg oligodeoxynucleotides - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cpg c dna  (Hycult Biotech)
92
Hycult Biotech cpg c dna
Cpg C Dna, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg c dna/product/Hycult Biotech
Average 92 stars, based on 1 article reviews
cpg c dna - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
cpg  (MedChemExpress)
93
MedChemExpress cpg
Cpg, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg/product/MedChemExpress
Average 93 stars, based on 1 article reviews
cpg - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
r848  (MedChemExpress)
94
MedChemExpress r848
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
R848, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/r848/product/MedChemExpress
Average 94 stars, based on 1 article reviews
r848 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
cpg odn 1826  (TriLink)
90
TriLink cpg odn 1826
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
Cpg Odn 1826, supplied by TriLink, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg odn 1826/product/TriLink
Average 90 stars, based on 1 article reviews
cpg odn 1826 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cpg odn odn 2166  (Source BioScience plc)
90
Source BioScience plc cpg odn odn 2166
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
Cpg Odn Odn 2166, supplied by Source BioScience plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg odn odn 2166/product/Source BioScience plc
Average 90 stars, based on 1 article reviews
cpg odn odn 2166 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cpg odn 2006  (MWG-Biotech ag)
90
MWG-Biotech ag cpg odn 2006
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
Cpg Odn 2006, supplied by MWG-Biotech ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg odn 2006/product/MWG-Biotech ag
Average 90 stars, based on 1 article reviews
cpg odn 2006 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cpg odn 1668  (GeneWorks)
90
GeneWorks cpg odn 1668
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
Cpg Odn 1668, supplied by GeneWorks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg odn 1668/product/GeneWorks
Average 90 stars, based on 1 article reviews
cpg odn 1668 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
oligodeoxynucleotide cpg odn1826  (TIB MOLBIOL)
90
TIB MOLBIOL oligodeoxynucleotide cpg odn1826
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
Oligodeoxynucleotide Cpg Odn1826, supplied by TIB MOLBIOL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligodeoxynucleotide cpg odn1826/product/TIB MOLBIOL
Average 90 stars, based on 1 article reviews
oligodeoxynucleotide cpg odn1826 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cpg oligodeoxynucleotides with a phosphorthioate backbone cpg-odn 1826  (Microsynth ag)
90
Microsynth ag cpg oligodeoxynucleotides with a phosphorthioate backbone cpg-odn 1826
LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist <t>R848</t> (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001
Cpg Oligodeoxynucleotides With A Phosphorthioate Backbone Cpg Odn 1826, supplied by Microsynth ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpg oligodeoxynucleotides with a phosphorthioate backbone cpg-odn 1826/product/Microsynth ag
Average 90 stars, based on 1 article reviews
cpg oligodeoxynucleotides with a phosphorthioate backbone cpg-odn 1826 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist R848 (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001

Journal: Cell Communication and Signaling : CCS

Article Title: Induction of LY6E regulates interleukin-1β production, potentially contributing to the immunopathogenesis of systemic lupus erythematosus

doi: 10.1186/s12964-025-02140-z

Figure Lengend Snippet: LY6E deficiency inhibited IL-1β expression induced by stimulation with IFN-α and ICs. BMDMs (2 × 10. 6 ) were electroporated with 300 nM LY6E siRNA (siLY6E) or control siRNA (siCtl) and then stimulated with or without various stimuli as indicated for 24 h. The concentrations of the individual stimuli used were as follows: the TLR7/8 agonist R848 (2.5 μg/ml), the TLR3 agonist PolyIC (10 μg/ml), LPS (100 ng/ml), IFN-α (100 U/ml), and ICs (10 μg/ml). The mRNA and protein levels of LY6E were determined by qPCR ( A ) and Western blotting ( B ), respectively. The mRNA expression of several inflammation-associated molecules induced by various stimuli with or without LY6E deficiency conditions was determined ( C ). The IFN-α- and IC-induced expression of IL-1β with or without LY6E knockdown was determined by Western blotting ( D and E ). Each data point represents one mouse, and the values are fold changes relative to the mean of the siCtl in RT‒qPCR and Western blotting. For Western blotting, the samples were derived from the same experiment, and both the gels and the blots were processed in parallel. Statistical analysis was performed with Student’s t test to compare the means between two groups (A and B) or two-way ANOVA with Holm‒Sidak’s multiple comparisons test to compare differences among different treatments ( D and E ). * P < 0.05, ** P < 0.01, **** P < 0.0001

Article Snippet: Lipopolysaccharide (LPS) (tlrl-3pelp), Pam3CSK4 (tlrl-pms), PolyIC (tlrl-picw), R848 (tlrl-r848), CpG ODN1826 (tlrl-1826), H151 (inh-h151), Ac-YVAD-cmk (HY-16990) and voltage-dependent anion channel oligomerization inhibitor (VBIT-4, HY129122) were purchased from MedChemExpress LLC (Monmouth Junction, NJ, USA).

Techniques: Expressing, Control, Western Blot, Knockdown, Derivative Assay